FindTrial
Sign In

Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns

Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04045626
Enrollment
20
Registered
2019-08-05
Start date
2019-08-01
Completion date
2020-03-31
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive Keratoconus

Brief summary

To assess depth of demarcation line in transepithelial versus epithelium-off accelerated cross-linking in keratoconus patients

Detailed description

Anterior segment optical coherence tomography OCT will be performed to evaluate the corneal stroma for the presence of demarcation line 1 month postoperatively by an independent observer unware of purpose of study

Interventions

PROCEDUREcorneal cross-linking

Riboflavin is instilled over cornea followed by Ultraviolet-A irradiation

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* progressive keratoconus stage 1-2

Exclusion criteria

* any concomitant ocular disease

Design outcomes

Primary

MeasureTime frameDescription
evaluation of depth of demarcation line1 month postoperativeAnterior segment optical coherence tomography AS-OCT is used to measure depth of demarcation line

Countries

Egypt

Contacts

Primary ContactSarah Azzam, MD
sarahazzam@ymail.com+201227425601

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026